Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

Publisher： Cambridge University Press

E-ISSN： 1601-5215|25|5|297-306

ISSN： 0924-2708

Source： Acta Neuropsychiatrica, Vol.25, Iss.5, 2013-03, pp. : 297-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder

By  

Acta Neuropsychiatrica, Vol. 22, Iss. 2, 2010-04 ,pp. : 68-80

Cambridge University Press

Access to resources Recommend Favorite

Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone

By  

International Psychogeriatrics, Vol. 20, Iss. 6, 2008-12 ,pp. : 1245-1250

Cambridge University Press

Access to resources Recommend Favorite

A Review on Thirty Days to Hope & Freedom from Sexual Addiction: The Essential Guide to Beginning Recovery and Relapse Prevention

By Lee Timothy  

Journal of Sex & Marital Therapy, Vol. 18, Iss. 1, 2011-01 ,pp. : 52-55

Routledge Ltd

Access to resources Recommend Favorite

Urinary incontinence and diarrhoea associated with the switch from oral to injectable risperidone

By  

Acta Neuropsychiatrica, Vol. 25, Iss. 2, 2013-02 ,pp. : 119-121

Cambridge University Press

Access to resources Recommend Favorite

The Relationship between Serum Prolactin Level and Sexual Functioning among Male Outpatients with Schizophrenia or Schizoaffective Disorder: A Randomized Double-Blind Trial of Risperidone vs. Quetiapine

By Nakonezny Paul   Byerly Matthew   Rush A. John  

Journal of Sex & Marital Therapy, Vol. 33, Iss. 3, 2007-05 ,pp. : 203-216

Routledge Ltd

Access to resources Recommend Favorite